Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

812 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms.
Shank K, Dunbar A, Koppikar P, Kleppe M, Teruya-Feldstein J, Csete I, Bhagwat N, Keller M, Kilpivaara O, Michor F, Levine RL, de Vargas Roditi L. Shank K, et al. Among authors: levine rl. Haematologica. 2020 Mar;105(3):e91-e94. doi: 10.3324/haematol.2018.203729. Epub 2019 Aug 14. Haematologica. 2020. PMID: 31413098 Free PMC article. No abstract available.
JAK2 and MPL mutations in myeloproliferative neoplasms.
Koppikar P, Levine RL. Koppikar P, et al. Among authors: levine rl. Acta Haematol. 2008;119(4):218-25. doi: 10.1159/000140634. Epub 2008 Jun 20. Acta Haematol. 2008. PMID: 18566540 Review.
Myeloproliferative disorders.
Levine RL, Gilliland DG. Levine RL, et al. Blood. 2008 Sep 15;112(6):2190-8. doi: 10.1182/blood-2008-03-077966. Blood. 2008. PMID: 18779404 Free PMC article. Review.
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL, Bass A, Marubayashi S, Heguy A, Garcia-Manero G, Kantarjian H, Offit K, Stone RM, Gilliland DG, Klein RJ, Levine RL. Kilpivaara O, et al. Among authors: levine rl. Nat Genet. 2009 Apr;41(4):455-9. doi: 10.1038/ng.342. Epub 2009 Mar 15. Nat Genet. 2009. PMID: 19287384 Free PMC article.
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL, Kantarjian HM, Stone RM, Gilliland DG, Crispino JD, Levine RL. Abdel-Wahab O, et al. Among authors: levine rl. Blood. 2009 Jul 2;114(1):144-7. doi: 10.1182/blood-2009-03-210039. Epub 2009 May 6. Blood. 2009. PMID: 19420352 Free PMC article.
A progenitor cell origin of myeloid malignancies.
Haeno H, Levine RL, Gilliland DG, Michor F. Haeno H, et al. Among authors: levine rl. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21. doi: 10.1073/pnas.0908107106. Epub 2009 Sep 21. Proc Natl Acad Sci U S A. 2009. PMID: 19805346 Free PMC article.
812 results